Your browser doesn't support javascript.
loading
Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.
Russell, Oliver M; Fruh, Isabelle; Rai, Pavandeep K; Marcellin, David; Doll, Thierry; Reeve, Amy; Germain, Mitchel; Bastien, Julie; Rygiel, Karolina A; Cerino, Raffaele; Sailer, Andreas W; Lako, Majlinda; Taylor, Robert W; Mueller, Matthias; Lightowlers, Robert N; Turnbull, Doug M; Helliwell, Stephen B.
Afiliación
  • Russell OM; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Fruh I; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Rai PK; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Marcellin D; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Doll T; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Reeve A; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Germain M; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Bastien J; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Rygiel KA; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Cerino R; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Sailer AW; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Lako M; Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
  • Taylor RW; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Mueller M; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Lightowlers RN; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK.
  • Turnbull DM; Wellcome Centre for Mitochondrial Research, Institutes of Neuroscience and Cellular and Molecular Bioscience, Newcastle University Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, Tyne and Wear, UK. doug.turnbull@newcastle.ac.uk.
  • Helliwell SB; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland. stephen.helliwell@novartis.com.
Sci Rep ; 8(1): 1799, 2018 01 29.
Article en En | MEDLINE | ID: mdl-29379065
ABSTRACT
We generated induced pluripotent stem cells (iPSCs) from patient fibroblasts to yield cell lines containing varying degrees of heteroplasmy for a m.13514 A > G mtDNA point mutation (2 lines) and for a ~6 kb single, large scale mtDNA deletion (3 lines). Long term culture of the iPSCs containing a single, large-scale mtDNA deletion showed consistent increase in mtDNA deletion levels with time. Higher levels of mtDNA heteroplasmy correlated with increased respiratory deficiency. To determine what changes occurred in deletion level during differentiation, teratomas comprising all three embryonic germ layers were generated from low (20%) and intermediate heteroplasmy (55%) mtDNA deletion clones. Regardless of whether iPSCs harbouring low or intermediate mtDNA heteroplasmy were used, the final levels of heteroplasmy in all teratoma germ layers increased to a similar high level (>60%). Thus, during human stem cell division, cells not only tolerate high mtDNA deletion loads but seem to preferentially replicate deleted mtDNA genomes. This has implications for the involvement of mtDNA deletions in both disease and ageing.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Mitocondrial / Eliminación de Secuencia Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Mitocondrial / Eliminación de Secuencia Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido